Pathology

Doç. Dr. Selma Şengız Erhan

Doctor and researcher Kartal Dr. Lütfi Kırdar Şehir Hastanesi İstanbul
Stomach NeoplasmsAdenocarcinomaThyroid NeoplasmsGallbladder DiseasesGallbladder Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Stomach Neoplasms 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Adenocarcinoma 3 publications
  • Thyroid Neoplasms 2 publications
  • Gallbladder Diseases 2 publications
  • Gallbladder Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPathologysaglik.gov.trFrom source
  • InstitutionKartal Dr. Lütfi Kırdar Şehir Hastanesisaglik.gov.trFrom source
  • Area of workStomach NeoplasmsExtracted from 4 publications · Model version —From source
  • Publications58 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0001-8810-8806ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://lutfikirdareah.saglik.gov.tr/TR-1478875/doktorlarimiz.html#selma-sengiz-erhansaglik.gov.tr

Scientific work

Publications on Stomach Neoplasms

58 publications

  1. Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinoma

    Journal of International Medical Research, 2026

    DOI 10.1177/03000605251386599 PMID 41521150 Open-access full textSource: OpenAlex

  2. Potential Immunomodulatory Role of IL-37+CD4+ Helper T Cells in Autoimmune Hepatitis

    Southern Clinics of Istanbul Eurasia, 2026

    DOI 10.14744/scie.2026.76992 Open-access full textSource: OpenAlex

  3. Granulomatous Thyroiditis: A Retrospective Analysis of 45 Cases with Histopathological Correlation

    Eurasian Journal of Medicine, 2026

    DOI 10.5152/eurasianjmed.2026.261553 Open-access full textSource: OpenAlex

  4. Can arid1a expression levels in gastric carcinomas predict response to neoadjuvant therapy and prognosis?

    Polish Journal of Pathology, 2026

    DOI 10.5114/pjp/235688 Open-access full textSource: OpenAlex

  5. Relación entre el estado de HER2 adquirido a partir de los datos patológicos y los parámetros metabólicos obtenidos mediante [18F]FDG PET/TC pretratamiento en adenocarcinomas gástricos

    Revista Española de Medicina Nuclear e Imagen Molecular, 2025

    DOI 10.1016/j.remn.2024.500080 Source: ORCID

  6. Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective

    Turkish journal of medical sciences, 2025

    DOI 10.55730/1300-0144.5944 PMID 40104288 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  7. Insulinoma in pregnancy: is diet alone enough to treat insulinoma?

    Endokrynologia Polska, 2025

    DOI 10.5603/ep.105639 PMID 41457635 1 citation (Europe PMC) Source: ORCID

  8. Does Celiac Disease Affect Smell Sensation, Mucociliary Clearance and Nasal Smear?

    kulak burun boğaz ve baş boyun cerrahisi dergisi, 2024

    DOI 10.24179/kbbbbc.2023-99179 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  9. Unusual Presence of Synchronous Primary Ovarian and Thyroid Extranodal Non-Hodgkin Lymphoma Without Lymph Node Involvement

    Clinical Nuclear Medicine, 2024

    DOI 10.1097/rlu.0000000000005108 PMID 38350088 2 citations (OpenAlex) Source: OpenAlex

  10. The relationship between HER2 status acquired from pathological data and metabolic parameters from pre-treatment [18F]FDG PET/CT in gastric adenocarcinomas

    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2024

    DOI 10.1016/j.remnie.2024.500080 PMID 39710040 1 citation (OpenAlex) Open-access full textSource: OpenAlex

View all 58 publications